Workflow
|
Enrollment
|
Allocation
|
Follow-up
|
Close-out
|
---|
− 7 days
|
Day 0
|
Day 1
|
Day 7
|
Day 14
|
Day 30
|
Day 60
|
Day 90
|
---|
Enrollment
|
Eligibility screening
| ✓ | | | | | | | |
Informed consent
| ✓ | | | | | | | |
Allocation
| | ✓ | | | | | | |
Interventions
|
FMT capsules
| | | ✓ | ✓ | ✓ | | | |
Placebo capsules
| | | ✓ | ✓ | ✓ | | | |
Assessments
|
Comorbid diseases and treatment
| ✓ | | | | | | | |
Physical examination
| ✓ | | | | | | | ✓ |
Office BP and heart rate
| ✓ | | | ✓ | ✓ | ✓ | ✓ | ✓ |
24-h ABPM
| ✓ | | | | | ✓ | | ✓ |
Blood routine
| ✓ | | | | | | | ✓ |
Urine routine
| ✓ | | | | | | | ✓ |
Blood chemical test
| ✓ | | | | | | | ✓ |
Urine microalbumin, creatinine
| ✓ | | | | | | | ✓ |
ECG
| ✓ | | | | | | | ✓ |
Arterial stiffness (ABI, PWV)
| ✓ | | | | | | | ✓ |
Diet records
| | | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
Patient compliance
| | | ✓ | ✓ | ✓ | | | |
Adverse events
| | | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
Combined medications for accompanied diseases
| | | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
Fecal sample collection
| ✓ | | | ✓ | ✓ | ✓ | ✓ | ✓ |
Blood sample collection
| ✓ | | | ✓ | ✓ | ✓ | ✓ | ✓ |
- Blood biochemical test: ALT alanine aminotransferase, AST aspartate aminotransferase, K potassium, Na sodium, Cl chloride, BUN urea nitrogen, CREA creatinine, UA uric acid, TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, GLU fasting blood glucose